濱化股份(601678.SH):前三季度淨利潤預增491.46%
格隆匯10月25日丨濱化股份(601678.SH)公佈了2021年前三季度業績預吿,公司預計實現前三季度歸屬於上市公司股東的淨利潤與上年同期相比,將增加11.72億元,同比增加491.46%;
預計第三季度實現歸屬於上市公司股東的淨利潤4.32億元,較第二季度減少10.88%。
本期業績預增的主要原因為:
主營業務影響:2021年前三季度,公司各裝置保持了穩定運行,主要產品產量保持穩定。受市場供求關係影響,主要產品環氧丙烷、三氯乙烯、環氧氯丙烷、四氯乙烯、氯丙烯等銷售價格同比有較大幅度上漲。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.